Summary

Persistence Market Research has recently released a comprehensive report on the worldwide market for vagus nerve stimulation (VNS). The report offers a thorough assessment of crucial market dynamics, including drivers, trends, opportunities, and challenges, providing detailed insights into the market structure.

Key Insights:

• Vagus Nerve Stimulation Market Size (2025E): USD 542.3 Mn
• Projected Market Value (2032F): USD 1,013.4 Mn
• Global Market Growth Rate (CAGR 2025 to 2032): 9.3%

Vagus Nerve Stimulation Market – Report Scope:

Vagus nerve stimulation plays a crucial role in the treatment of various chronic and neurological conditions, including drug-resistant epilepsy, treatment-resistant depression, and migraines. These devices work by sending electrical impulses to the vagus nerve, modulating neural circuits involved in mood, seizure activity, and pain. The vagus nerve stimulation market caters to hospitals, neurological clinics, ambulatory surgical centers, and homecare settings, offering a range of device types, including implantable and non-invasive VNS systems. Market growth is driven by increasing prevalence of neurological disorders, growing preference for neuromodulation over pharmacological therapies, and technological advancements enhancing patient outcomes and comfort.

Market Growth Drivers:

The global vagus nerve stimulation market is propelled by several key factors, including the rising global burden of neurological conditions such as epilepsy and depression. Growing awareness about VNS as an effective, non-drug-based therapy has led to increased adoption in clinical settings. Additionally, regulatory approvals for expanded indications, such as migraine and inflammatory conditions, further stimulate market expansion. Technological innovations, such as the development of wearable non-invasive VNS devices and miniaturized implantable systems, provide improved treatment outcomes and increase patient compliance. The rising demand for personalized and remote treatment options also supports market growth.

Market Restraints:

Despite promising growth prospects, the vagus nerve stimulation market faces challenges related to high treatment costs, surgical risks (for implantable devices), and reimbursement limitations in several regions. Stringent regulatory frameworks governing neuromodulation devices can delay product approvals and increase the cost of development. Moreover, lack of awareness among general practitioners and patients about the potential benefits of VNS therapy limits broader market penetration. Concerns about the long-term safety and efficacy of the devices in off-label applications also pose challenges for market players.

Market Opportunities:

The vagus nerve stimulation market presents significant growth opportunities driven by non-invasive VNS technologies that eliminate surgical risks and offer greater accessibility. Integration with digital health technologies, such as remote monitoring systems and mobile apps, enhances patient engagement and enables physicians to optimize therapy remotely. Additionally, ongoing research into the application of VNS for emerging conditions—such as anxiety, PTSD, Alzheimer’s disease, and gastrointestinal disorders—broadens the therapeutic landscape. Strategic collaborations, increased funding for neuromodulation research, and user-friendly device innovations are crucial to capitalizing on these opportunities and expanding the market globally.

Key Questions Answered in the Report:

• What are the primary factors driving the growth of the vagus nerve stimulation market globally?
• Which device types and applications are driving VNS adoption across different healthcare settings?
• How are technological advancements reshaping the competitive landscape of the vagus nerve stimulation market?
• Who are the key players contributing to the vagus nerve stimulation market, and what strategies are they employing to maintain market relevance?
• What are the emerging trends and future prospects in the global vagus nerve stimulation market?

Competitive Intelligence and Business Strategy:

These companies invest in R\&D to develop advanced VNS systems, including minimally invasive and wearable formats, catering to a range of patient needs and medical conditions. Collaborations with healthcare providers, academic research centers, and digital health firms facilitate clinical trials, device integration, and market access. Moreover, emphasis on patient-centric care models, regulatory engagement, and clinical evidence supports broader adoption and enhances patient outcomes in the rapidly evolving VNS landscape.

Key Companies Profiled:

• Soterix Medical Inc.
• LivaNova PLC
• SetPoint Medical
• Vagutism
• tVNS Technologies GmbH
• electroCore, Inc.
• Adriakaim, Inc.
• MicroTransponder Inc.
• Parasym, Ltd.
• Pulsetto
• Teliatry, Inc.
• biolitec® Holding GmbH & Co KG
• AURIMOD GMBH
• Evren Technologies, Inc.
• NeurGear
• Hoolest
• Neuvana
• BioSelf Technology Ltd.

Vagus Nerve Stimulation Market Research Segmentation:

By Product:

• Implantable VNS Device
• External Non-invasive VNS Device

By Application:

• Epilepsy
• Depression
• Migraine
• Others

By End-user:

• Hospitals
• Specialty Clinics
• Ambulatory Surgical Centres
• Academic & Research Institutes
• Others

By Region:

• North America
• Europe
• East Asia
• South Asia and Oceania
• Latin America
• Middle East and Africa

ページTOPに戻る

Table of Contents

1. Executive Summary
1.1. Global Vagus Nerve Stimulation Market Snapshot, 2025 and 2032
1.2. Market Opportunity Assessment, 2025-2032, US$ Mn
1.3. Key Market Trends
1.4. Future Market Projections
1.5. Premium Market Insights
1.6. Industry Developments and Key Market Events
1.7. PMR Analysis and Recommendations
2. Market Overview
2.1. Market Scope and Definition
2.2. Market Dynamics
2.2.1. Drivers
2.2.2. Restraints
2.2.3. Opportunity
2.2.4. Key Trends
2.3. Macro-Economic Factors
2.3.1. Global Sectorial Outlook
2.3.2. Global GDP Growth Outlook
2.4. COVID-19 Impact Analysis
2.5. Forecast Factors - Relevance and Impact
3. Value Added Insights
3.1. Product Adoption Analysis
3.2. Regulatory Landscape
3.3. Value Chain Analysis
3.4. Key Deals and Mergers
3.5. PESTLE Analysis
3.6. Porter’s Five Force Analysis
4. Price Analysis, 2024A
4.1. Key Highlights
4.2. Key Factors Impacting Product Prices
4.3. Pricing Analysis, By Product
4.4. Regional Prices and Product Preferences
5. Global Vagus Nerve Stimulation Market Outlook
5.1. Key Highlights
5.1.1. Market Volume (Units) Projections
5.1.2. Market Size (US$ Mn) and Y-o-Y Growth
5.1.3. Absolute $ Opportunity
5.2. Market Size (US$ Mn) Analysis and Forecast
5.2.1. Historical Market Size (US$ Mn) Analysis, 2019-2024
5.2.2. Market Size (US$ Mn) Analysis and Forecast, 2025-2032
5.3. Global Vagus Nerve Stimulation Market Outlook: Product
5.3.1. Introduction / Key Findings
5.3.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis, By Product, 2019-2024
5.3.3. Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Product, 2025-2032
5.3.3.1. Implantable VNS Device
5.3.3.2. External Non-invasive VNS Device
5.3.4. Market Attractiveness Analysis: Product
5.4. Global Vagus Nerve Stimulation Market Outlook: Application
5.4.1. Introduction / Key Findings
5.4.2. Historical Market Size (US$ Mn) Analysis, By Application, 2019-2024
5.4.3. Market Size (US$ Mn) Analysis and Forecast, By Application, 2025-2032
5.4.3.1. Epilepsy
5.4.3.2. Depression
5.4.3.3. Migraine
5.4.3.4. Others
5.4.4. Market Attractiveness Analysis: Application
5.5. Global Vagus Nerve Stimulation Market Outlook: End User
5.5.1. Introduction / Key Findings
5.5.2. Historical Market Size (US$ Mn) Analysis, By End User, 2019-2024
5.5.3. Market Size (US$ Mn) Analysis and Forecast, By End User, 2025-2032
5.5.3.1. Hospitals
5.5.3.2. Specialty Clinics
5.5.3.3. Ambulatory Surgical Centers
5.5.3.4. Academic & Research Institutes
5.5.3.5. Others
5.5.4. Market Attractiveness Analysis: End User
6. Global Vagus Nerve Stimulation Market Outlook: Region
6.1. Key Highlights
6.2. Historical Market Size (US$ Mn) Analysis, By Region, 2019-2024
6.3. Market Size (US$ Mn) Analysis and Forecast, By Region, 2025-2032
6.3.1. North America
6.3.2. Europe
6.3.3. East Asia
6.3.4. South Asia and Oceania
6.3.5. Latin America
6.3.6. Middle East & Africa
6.4. Market Attractiveness Analysis: Region
7. North America Vagus Nerve Stimulation Market Outlook
7.1. Key Highlights
7.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
7.2.1. By Country
7.2.2. By Product
7.2.3. By Application
7.2.4. By End User
7.3. Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
7.3.1. U.S.
7.3.2. Canada
7.4. Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Product, 2025-2032
7.4.1. Implantable VNS Device
7.4.2. External Non-invasive VNS Device
7.5. Market Size (US$ Mn) Analysis and Forecast, By Application, 2025-2032
7.5.1. Epilepsy
7.5.2. Depression
7.5.3. Migraine
7.5.4. Others
7.6. Market Size (US$ Mn) Analysis and Forecast, By End User, 2025-2032
7.6.1. Hospitals
7.6.2. Specialty Clinics
7.6.3. Ambulatory Surgical Centers
7.6.4. Academic & Research Institutes
7.6.5. Others
7.7. Market Attractiveness Analysis
8. Europe Vagus Nerve Stimulation Market Outlook
8.1. Key Highlights
8.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
8.2.1. By Country
8.2.2. By Product
8.2.3. By Application
8.2.4. By End User
8.3. Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
8.3.1. Germany
8.3.2. France
8.3.3. U.K.
8.3.4. Italy
8.3.5. Spain
8.3.6. Russia
8.3.7. Turkey
8.3.8. Rest of Europe
8.4. Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Product, 2025-2032
8.4.1. Implantable VNS Device
8.4.2. External Non-invasive VNS Device
8.5. Market Size (US$ Mn) Analysis and Forecast, By Application, 2025-2032
8.5.1. Epilepsy
8.5.2. Depression
8.5.3. Migraine
8.5.4. Others
8.6. Market Size (US$ Mn) Analysis and Forecast, By End User, 2025-2032
8.6.1. Hospitals
8.6.2. Specialty Clinics
8.6.3. Ambulatory Surgical Centers
8.6.4. Academic & Research Institutes
8.6.5. Others
8.7. Market Attractiveness Analysis
9. East Asia Vagus Nerve Stimulation Market Outlook
9.1. Key Highlights
9.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
9.2.1. By Country
9.2.2. By Product
9.2.3. By Application
9.2.4. By End User
9.3. Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
9.3.1. China
9.3.2. Japan
9.3.3. South Korea
9.4. Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Product, 2025-2032
9.4.1. Implantable VNS Device
9.4.2. External Non-invasive VNS Device
9.5. Market Size (US$ Mn) Analysis and Forecast, By Application, 2025-2032
9.5.1. Epilepsy
9.5.2. Depression
9.5.3. Migraine
9.5.4. Others
9.6. Market Size (US$ Mn) Analysis and Forecast, By End User, 2025-2032
9.6.1. Hospitals
9.6.2. Specialty Clinics
9.6.3. Ambulatory Surgical Centers
9.6.4. Academic & Research Institutes
9.6.5. Others
9.7. Market Attractiveness Analysis
10. South Asia & Oceania Vagus Nerve Stimulation Market Outlook
10.1. Key Highlights
10.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
10.2.1. By Country
10.2.2. By Product
10.2.3. By Application
10.2.4. By End User
10.3. Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
10.3.1. India
10.3.2. Southeast Asia
10.3.3. ANZ
10.3.4. Rest of South Asia & Oceania
10.4. Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Product, 2025-2032
10.4.1. Implantable VNS Device
10.4.2. External Non-invasive VNS Device
10.5. Market Size (US$ Mn) Analysis and Forecast, By Application, 2025-2032
10.5.1. Epilepsy
10.5.2. Depression
10.5.3. Migraine
10.5.4. Others
10.6. Market Size (US$ Mn) Analysis and Forecast, By End User, 2025-2032
10.6.1. Hospitals
10.6.2. Specialty Clinics
10.6.3. Ambulatory Surgical Centers
10.6.4. Academic & Research Institutes
10.6.5. Others
10.7. Market Attractiveness Analysis
11. Latin America Vagus Nerve Stimulation Market Outlook
11.1. Key Highlights
11.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
11.2.1. By Country
11.2.2. By Product
11.2.3. By Application
11.2.4. By End User
11.3. Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
11.3.1. Brazil
11.3.2. Mexico
11.3.3. Rest of Latin America
11.4. Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Product, 2025-2032
11.4.1. Implantable VNS Device
11.4.2. External Non-invasive VNS Device
11.5. Market Size (US$ Mn) Analysis and Forecast, By Application, 2025-2032
11.5.1. Epilepsy
11.5.2. Depression
11.5.3. Migraine
11.5.4. Others
11.6. Market Size (US$ Mn) Analysis and Forecast, By End User, 2025-2032
11.6.1. Hospitals
11.6.2. Specialty Clinics
11.6.3. Ambulatory Surgical Centers
11.6.4. Academic & Research Institutes
11.6.5. Others
11.7. Market Attractiveness Analysis
12. Middle East & Africa Vagus Nerve Stimulation Market Outlook
12.1. Key Highlights
12.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
12.2.1. By Country
12.2.2. By Product
12.2.3. By Application
12.2.4. By End User
12.3. Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
12.3.1. GCC Countries
12.3.2. Egypt
12.3.3. South Africa
12.3.4. Northern Africa
12.3.5. Rest of Middle East & Africa
12.4. Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Product, 2025-2032
12.4.1. Implantable VNS Device
12.4.2. External Non-invasive VNS Device
12.5. Market Size (US$ Mn) Analysis and Forecast, By Application, 2025-2032
12.5.1. Epilepsy
12.5.2. Depression
12.5.3. Migraine
12.5.4. Others
12.6. Market Size (US$ Mn) Analysis and Forecast, By End User, 2025-2032
12.6.1. Hospitals
12.6.2. Specialty Clinics
12.6.3. Ambulatory Surgical Centers
12.6.4. Academic & Research Institutes
12.6.5. Others
12.7. Market Attractiveness Analysis
13. Competition Landscape
13.1. Market Share Analysis, 2024
13.2. Market Structure
13.2.1. Competition Intensity Mapping By Market
13.2.2. Competition Dashboard
13.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
13.3.1. Soterix Medical Inc.
13.3.1.1. Overview
13.3.1.2. Segments and Product
13.3.1.3. Key Financials
13.3.1.4. Market Developments
13.3.1.5. Market Strategy
13.3.2. LivaNova PLC
13.3.3. SetPoint Medical
13.3.4. Vagutism
13.3.5. tVNS Technologies GmbH
13.3.6. electroCore, Inc.
13.3.7. Adriakaim, Inc.
13.3.8. MicroTransponder Inc.
13.3.9. Parasym, Ltd.
13.3.10. Pulsetto
13.3.11. Teliatry, Inc.
13.3.12. biolitec® Holding GmbH & Co KG
13.3.13. AURIMOD GMBH
13.3.14. Evren Technologies, Inc.
13.3.15. NeurGear
13.3.16. Hoolest
13.3.17. Neuvana
13.3.18. BioSelf Technology Ltd.
14. Appendix
14.1. Research Methodology
14.2. Research Assumptions
14.3. Acronyms and Abbreviations